Epitranscriptomic RNA m6A Modification in Cancer Therapy Resistance: Challenges and Unrealized Opportunities is a research paper published in Advanced Science (2024). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Foundation for the National Institutes of Health
Grant: R01ES029942
Foundation for the National Institutes of Health
Grant: R01ES032787
NIEHS NIH HHS
Grant: R01 ES029496
NIEHS NIH HHS
Grant: R01 ES028256
National Institutes of Health
Grant: 5R01ES028256-03
Epigenetic mechanism of the synergistic tumorigenic effect of arsenic and benzo[a]pyrene co-exposure
National Institutes of Health
Grant: 1R01ES029496-01A1
MGMT down-regulation in the carcinogenicity of hexavalent chromium
National Institutes of Health
Grant: 5R01ES032787-05
Dysregulations of functional RNA modifications and hexavalent chromium lungcarcinogenesis
National Institutes of Health
Grant: 7R01ES029942-03
MECHANISM OF HEXAVALENT CHROMIUM CARCINOGENESIS ROLE OF LONG NON-CODING RNA DYSREGULATION
Fields of Study
Keywords